US 9493432
Cyclopentylbenzamide derivatives and their use for the treatment of psychotic and cognitive disorders
granted A61KA61K31/423A61K31/428
Quick answer
US patent 9493432 (Cyclopentylbenzamide derivatives and their use for the treatment of psychotic and cognitive disorders) held by Takeda Pharmaceutical Company Limited expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/423, A61K31/428, A61K31/47, A61K31/498